66 Biggest Movers From Friday
Gainers
GeoVax Labs, Inc. (NASDAQ: GOVX) shares surged 90.2% to settle at $1.39 on Friday. GeoVax Labs, last month, said its Q1 sales results were lower year over year.
Earnings Scheduled For March 23, 2022
Companies Reporting Before The Bell
• AYRO (NASDAQ:AYRO) is expected to report earnings for its fourth quarter.
Journey Medical Corporation Announces First Patient Dosed In Phase 3 Clinical Trial Evaluating DFD-29 (Minocycline Modified Release Capsules 40 Mg) For The Treatment Of Rosacea
Journey Medical Corporation (NASDAQ:DERM) ("Journey Medical"), a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of
VYNE Therapeutics Divests Topical Minocycline Assets; Transaction Includes Cash Payments Of $25M And Potential Milestones Of Up To $450M
Transaction includes cash payments of $25 million and potential milestones of up to $450 million
Sale aligns with VYNE's strategic plan; proceeds will be used to fund development of Company's
Roth Capital Initiates Coverage On Journey Medical with Buy Rating, Announces Price Target of $15
Roth Capital analyst Scott Henry initiates coverage on Journey Medical (NASDAQ:DERM) with a Buy rating and announces Price Target of $15.